Certara, Inc. (CERT) vs Maze Therapeutics, Inc. (MAZE)

A side-by-side comparison of Certara, Inc. and Maze Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

CERT

Certara, Inc.

$1.49B

$9.55HealthcareDelayed quote: Oct 6, 2026, 10:45 AM EDT

MAZE

Maze Therapeutics, Inc.

$1.44B

$26.00HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT

Total return — CERT vs MAZE

growth of $100 · dividends reinvested · last 2y

CERT -29.2% (-15.9%/yr)MAZE +65.7% (+28.7%/yr)MAZE compounded faster over this window

CERT MAZE

CERT vs MAZE: by the numbers

•CERT is the larger company ($1.49B vs $1.44B market cap).
•Both run net losses; CERT's is the smaller (-16.75% vs -667.95% net margin).

Metrics side by side

Valuation

Metric	CERT	MAZE
Forward P/E	28.04	N/A
P/S ratio	3.64	71.94
P/B ratio	1.54	3.18
EV / EBITDA	26.98	N/A
FCF yield	4.15%	N/A

Profitability

Metric	CERT	MAZE
Gross margin	58.33%	0.00%
Operating margin	1.86%	0.00%
Net margin	-16.75%	-667.95%
ROE	-7.08%	-29.48%
ROIC	0.59%	-28.63%

Growth (annualized)

Metric	CERT	MAZE
Revenue CAGR (5Y)	9.31%	N/A
FCF CAGR (5Y)	8.78%	N/A
Total return CAGR (5Y)	-21.31%	N/A

Go deeper

Full CERT analysis Full MAZE analysis Interactive comparison tool

Dig into the metrics

Certara ROE Maze Therapeutics ROE Certara operating margin Maze Therapeutics operating margin Certara revenue growth Maze Therapeutics revenue growth Certara free cash flow Maze Therapeutics free cash flow

Certara & Maze Therapeutics appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.